Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
2002 2
2003 2
2006 2
2009 1
2010 1
2013 1
2015 1
2017 2
2018 1
2019 2
2020 1
2021 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Ogbuagu O, Ruane PJ, Podzamczer D, Salazar LC, Henry K, Asmuth DM, Wohl D, Gilson R, Shao Y, Ebrahimi R, Cox S, Kintu A, Carter C, Das M, Baeten JM, Brainard DM, Whitlock G, Brunetta JM, Kronborg G, Spinner CD; DISCOVER study team. Ogbuagu O, et al. Lancet HIV. 2021 Jul;8(7):e397-e407. doi: 10.1016/S2352-3018(21)00071-0. Lancet HIV. 2021. PMID: 34197772 Clinical Trial.
Infected atrial myxoma.
Awab A, Hamadani M, Sud B, Voskuhl GW. Awab A, et al. Among authors: voskuhl gw. Med J Aust. 2006 Sep 18;185(6):332. doi: 10.5694/j.1326-5377.2006.tb00590.x. Med J Aust. 2006. PMID: 16999677 No abstract available.
Tickborne infections in the southern United States.
Salinas LJ, Greenfield RA, Little SE, Voskuhl GW. Salinas LJ, et al. Among authors: voskuhl gw. Am J Med Sci. 2010 Sep;340(3):194-201. doi: 10.1097/MAJ.0b013e3181e93817. Am J Med Sci. 2010. PMID: 20697259 Review.
Viral agents as biological weapons and agents of bioterrorism.
Bronze MS, Huycke MM, Machado LJ, Voskuhl GW, Greenfield RA. Bronze MS, et al. Among authors: voskuhl gw. Am J Med Sci. 2002 Jun;323(6):316-25. doi: 10.1097/00000441-200206000-00004. Am J Med Sci. 2002. PMID: 12074486 Review.
Bacterial pathogens as biological weapons and agents of bioterrorism.
Greenfield RA, Drevets DA, Machado LJ, Voskuhl GW, Cornea P, Bronze MS. Greenfield RA, et al. Among authors: voskuhl gw. Am J Med Sci. 2002 Jun;323(6):299-315. doi: 10.1097/00000441-200206000-00003. Am J Med Sci. 2002. PMID: 12074485 Review.
Lung abscess caused by Clostridium ramosum.
Nanda N, Voskuhl GW. Nanda N, et al. Among authors: voskuhl gw. J Okla State Med Assoc. 2006 Apr;99(4):158-60. J Okla State Med Assoc. 2006. PMID: 16703936
Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.
Walmsley SL, Antela A, Clumeck N, Duiculescu D, Eberhard A, Gutiérrez F, Hocqueloux L, Maggiolo F, Sandkovsky U, Granier C, Pappa K, Wynne B, Min S, Nichols G; SINGLE Investigators. Walmsley SL, et al. N Engl J Med. 2013 Nov 7;369(19):1807-18. doi: 10.1056/NEJMoa1215541. N Engl J Med. 2013. PMID: 24195548 Free article. Clinical Trial.
Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials.
Lathouwers E, Wong EY, Brown K, Baugh B, Ghys A, Jezorwski J, Mohsine EG, Van Landuyt E, Opsomer M, De Meyer S; AMBER and EMERALD Study Groups. Lathouwers E, et al. AIDS Res Hum Retroviruses. 2020 Jan;36(1):48-57. doi: 10.1089/AID.2019.0111. Epub 2019 Oct 21. AIDS Res Hum Retroviruses. 2020. PMID: 31516033 Free PMC article. Clinical Trial.
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1.
Eron JJ, Orkin C, Cunningham D, Pulido F, Post FA, De Wit S, Lathouwers E, Hufkens V, Jezorwski J, Petrovic R, Brown K, Van Landuyt E, Opsomer M; EMERALD study group. Eron JJ, et al. Antiviral Res. 2019 Oct;170:104543. doi: 10.1016/j.antiviral.2019.104543. Epub 2019 Jul 4. Antiviral Res. 2019. PMID: 31279073 Free article. Clinical Trial.
16 results